R&I

Bracco Research & Innovation

The research centers of the Bracco Group in the world

For years the Bracco Group has been investing substantial resources in research, pre-clinical and clinical development of Imaging Agents for in vivo imaging. IA are used with special equipment to provide physicians with detailed information for diagnoses and to monitor minimally invasive operating procedures. Technological advances in equipment, combined with IA, permit a very high level of diagnostic accuracy and procedure monitoring for most pathologies.

Iopamidol, the first molecule discovered and developed by Bracco in 1981, was followed by other IA created, developed and marketed by Bracco for X-ray, Magnetic Resonance, Ultrasound and Nuclear Medicine.

In the last few years, the Group has acquired competences and research skills in imaging-related sectors such as automatic IA delivery systems – at the Acist laboratories in Minneapolis, USA – and medical software for quantitative analysis of images. Its research work has a specific goal: to improve and facilitate diagnostic accuracy and treatment procedures to optimize medical services for patients.

Innovation centers

R&D work is organized and performed in the Group’s centers in Colleretto Giacosa, near Ivrea (CRB – Bracco Research Center), Geneva (Bracco Suisse S.A.) and USA, (Fremont - Silicon Valley, Princeton - New Jersey, Minneapolis e Maple Grove - Minnesota), which together form one of the world’s most important know-how networks. The three centers – whose competences are geared to continuous innovation– work on a coordinated basis.
The Research Centers in Ivrea and in Ginevra are mainly active in the initial discovery phase of new molecules and new sustainable processes; Princeton then transforms the discovery into products for human users.

By integrating groups with disparate approaches and cultures, the network maximizes their respective areas of expertise: the USA leads the way today in innovation, particularly in molecular medicine; both research centers contribute to this cutting-edge research where ultrasound, magnetic resonance and nuclear imaging are the most promising techniques.

A total of approximately 300 scientists and engineers (12 per cent of the workforce) work in Bracco R&D:
their daily contribution fuels the drive for innovation to meet user and market needs.
The training provided for Group personnel – young, highly specialized and with know-how in complementary fi elds – and the availability of state-of-the-art laboratory equipment are the foundations for competitiveness in line with the top international standards. This philosophy, shared across the entire Group, translates effectively into dynamic and constantly updated organizational models and is the cornerstone of Bracco operations. Overall, the Bracco Group invests 10% of its Diagnostic Imaging revenues in R&D.

A worldwide network

The activities of the three centers are flanked by the clinical trials and regulatory activities coordinated at global level by the Worldwide Medical and Regulatory Affairs division based in Princeton, with offices in Europe (Milan and Konstanz), Japan and China. The Bracco research network works on an open basis with university centers and public and private clinical research bodies, innovators in a sector making continuous scientific and business progress. The Group is involved in wide-ranging Italian, European and American projects as a member of an active network of partnerships.

In Italy in particular, the decision to conduct laboratory work in research-intensive regions like Piedmont, Lombardy, Friuli Venezia Giulia and Campania means Bracco Imaging can be active in early exploratory work integrated with genome, biomedical, biotechnological and sustainable chemical research in the various areas.

Bracco WorldWide

Bracco WorldWide

The Bracco Group, through its subsidiary Bracco Imaging operates throughout the world both directly or indirectly.

Bracco WorldWide

Read more

Diagnostic Imaging

Diagnostic Imaging

Bracco Imaging is an international leader in diagnostic imaging.

Diagnostic Imaging

Read more

Bracco Group's History

Our History

The Bracco Group exists since 1927, when Elio Bracco founded the Italian E. Merck company branch.

Bracco Group's History

Read more